Atea Pharmaceuticals, Inc (AVIR) insider trading
Every open-market stock purchase and sale by Atea Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Polly A. Murphy (Insider), $25.4K, 4 months ago.
Last 12 months: insiders bought $25.4K (1 buy) and sold $0 (0 sales).
Recent AVIR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 18, 2026 | Jerome M. Adams (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Franklin M Berger (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Polly A. Murphy (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Arthur S Kirsch (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Arthur S Kirsch (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Polly A. Murphy (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Bruce Polsky (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Bruce Polsky (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Jerome M. Adams (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Bruce Polsky (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Jerome M. Adams (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Barbara Gayle Duncan (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Barbara Gayle Duncan (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Howard Berman (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Howard Berman (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Franklin M Berger (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Bruno Lucidi (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Bruno Lucidi (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Franklin M Berger (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Barbara Gayle Duncan (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Bruno Lucidi (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Polly A. Murphy (Insider) | Bought (not open market) | — |
| May 18, 2026 | Polly A. Murphy (Insider) | Bought | $25.4K |
| Mar 11, 2026 | Andrea Corcoran (Insider) | Bought (not open market) | — |
| Feb 3, 2026 | Jean-Pierre Sommadossi (CEO) | Bought (not open market) | — |
Who's trading AVIR
- Arthur S Kirsch, Insider: other filings, last Jun 18, 2026
- Bruno Lucidi, Insider: other filings, last Jun 18, 2026
- Polly A. Murphy, Insider: bought $25.4K (1 buy), last Jun 18, 2026
- Bruce Polsky, Insider: other filings, last Jun 18, 2026
- Barbara Gayle Duncan, Insider: other filings, last Jun 18, 2026
- Jerome M. Adams, Insider: other filings, last Jun 18, 2026
- Franklin M Berger, Insider: other filings, last Jun 18, 2026
- Howard Berman, Insider: other filings, last Jun 18, 2026
- Andrea Corcoran, Insider: other filings, last Mar 11, 2026
- Jean-Pierre Sommadossi, CEO: other filings, last Feb 3, 2026
- John Vavricka, C-suite exec: other filings, last Jan 31, 2026
- Wayne Foster, C-suite exec: other filings, last Jan 31, 2026
- Janet MJ Hammond, C-suite exec: other filings, last Jan 31, 2026
- Maria Arantxa Horga, C-suite exec: other filings, last Jan 31, 2026
Get free alerts when an insider at Atea Pharmaceuticals, Inc files a new trade →